$4.020
-0.117 (-2.90%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GALT por análisis de gráficos similares
Alphio's GALT stock price prediction model matches the current Galectin Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.00 (-0.60%). The 1-week path is $3.96 (-1.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Galectin Therapeutics Inc?
Galectin Therapeutics Inc (GALT) is a good buy right now due to its recent price momentum and strategic clinical advancements. The current price is $4.02, with a 5-day change of +9.24% and a 20-day change of +35.35%. Despite a wider loss reported in Q2, the company is progressing with its Phase 3 trial design for belapectin, which could enhance its market position. The RSI is at 67.055, indicating strong momentum. However, the main risk is the increasing net loss, which reached $9.11 million in Q2, reflecting ongoing financial challenges.
GALT cerró en $4.02 el Friday, tras bajar -2.90%
Galectin Therapeutics Inc (GALT) last closed at $4.02, losing -2.90%. These facts feed the 1-day and 1-week GALT price prediction above.
Consenso de analistas
Galectin Therapeutics Inc (GALT): 3 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Galectin Therapeutics Inc (GALT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GALT, ordenadas por similitud.
Análisis de estacionalidad de GALT
Historically the probability of a positive August return for GALT is 71.43%. September offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GALT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $2.80 | $2.85 | $3.11 | -29.11% |
| Sep 2026 | $2.48 | $3.01 | $3.26 | -25.03% |
| Oct 2026 | $2.59 | $2.79 | $3.00 | -30.57% |
| Nov 2026 | $2.21 | $2.50 | $2.53 | -37.84% |
| Dec 2026 | $2.90 | $3.34 | $3.84 | -16.79% |
En 2026, se proyecta que Galectin Therapeutics Inc (GALT) oscile entre $2.21 y $3.84.
Previsión mensual de Galectin Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Galectin Therapeutics Inc promedie $2.85, con un mínimo de $2.80 y un máximo de $3.11.
En Sep de 2026, se proyecta que Galectin Therapeutics Inc promedie $3.01, con un mínimo de $2.48 y un máximo de $3.26.
En Oct de 2026, se proyecta que Galectin Therapeutics Inc promedie $2.79, con un mínimo de $2.59 y un máximo de $3.00.
En Nov de 2026, se proyecta que Galectin Therapeutics Inc promedie $2.50, con un mínimo de $2.21 y un máximo de $2.53.
En Dec de 2026, se proyecta que Galectin Therapeutics Inc promedie $3.34, con un mínimo de $2.90 y un máximo de $3.84.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.